Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Common-Size Income Statement
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Return on Assets (ROA) since 2012
- Debt to Equity since 2012
- Total Asset Turnover since 2012
- Price to Book Value (P/BV) since 2012
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Current Enterprise Value (EV)
Current share price (P) | |
No. shares of common stock outstanding | |
US$ in millions | |
Common equity (market value)1 | |
Add: Noncontrolling interest (per books) | |
Total equity | |
Add: Short-term borrowings (per books) | |
Add: Current portion of long-term debt and finance lease obligations (per books) | |
Add: Long-term debt and finance lease obligations, excluding current portion (per books) | |
Total equity and debt | |
Less: Cash and equivalents | |
Less: Short-term investments | |
Enterprise value (EV) |
Based on: 10-K (reporting date: 2024-12-31).
1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
Historical Enterprise Value (EV)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 Data adjusted for splits and stock dividends.
2 Closing price as at the filing date of AbbVie Inc. Annual Report.
3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×
The financial data reveals a consistent upward trend across the key capital structure metrics over the five-year period under review.
- Common Equity (Market Value)
- This metric shows a steady increase each year, rising from $185,435 million in 2020 to $340,484 million in 2024. This growth indicates a significant appreciation in market valuation of the company's equity, reflecting positive market sentiment or operational performance enhancements.
- Total Equity
- Total equity closely follows the same upward trajectory as common equity, starting at $185,456 million in 2020 and reaching $340,523 million by 2024. The parallel movement between common equity and total equity suggests limited influence from other equity components such as preferred stock, indicating the majority of equity is common stock.
- Total Equity and Debt
- The combined metric of equity and debt demonstrates moderate growth, increasing from $271,512 million in 2020 to $407,667 million in 2024. While the absolute increase is notable, the growth pace is somewhat slower relative to the increase in common equity alone, suggesting a relatively stable or controlled use of debt financing.
- Enterprise Value (EV)
- Enterprise value reflects the overall valuation of the company by the market, incorporating equity and debt minus cash and equivalents. EV has increased from $263,033 million in 2020 to $402,112 million in 2024, showing a consistent rise parallel to both equity and total capital employed metrics. This trend indicates improving market perception and possibly capitalization on growth opportunities.
Overall, the data shows strengthening financial position with increasing market valuation and equity base supported by stable debt levels. The consistent increase in enterprise value aligns with the expanding capital base, suggesting positive investor confidence and value creation over the period assessed.